. 2020 Aug 3;18:260. doi: 10.1186/s12955-020-01497-8

Table 4.

Correlation analysis: convergent validity

	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15
1 CPAQ_AE	1^*
2 CPAQ_PW	.59^*	1^*
3 CPAQ_total	.93^*	.85^*	1^*
4 FAH II	−.59^*	−.65^*	−.69^*	1^*
5 MPI - interference	−.63^*	−.46^*	−.63^*	.45^*	1^*
6 BPI - interference	−.51^*	−.4^*	−.52^*	.43^*	.76^*	1^*
7 PHQ	−.5^*	−.49^*	−.55^*	.64^*	.58^*	.61^*	1^*
8 GAD	−.39^*	−.48^*	−.48^*	.68^*	.39^*	.42^*	.78^*	1^*
9 NRS	−.38^*	−.23^*	−.35^*	.22^*	.73^*	.77^*	.43^*	.22^*	1^*
10 SF12_PCS	.34^*	.19	.31^*	−.05	−.54^*	−.48^*	−.2	.01	−.55^*	1^*
11 SF12_MCS	.53^*	.5^*	.58^*	−.76^*	−.47^*	−.45^*	−.77^*	−.74^*	−.22^*	−.12	1^*
12 CAQ-8-G	.54^*	.48^*	.58^*	−.67^*	−.31^*	−.28^*	−.48^*	−.49^*	−.12	.02	.57^*	1^*
13 CAQ-G_Neg	.39^*	.43^*	.45^*	−.63^*	−.22^*	−.2	−.38^*	−.48^*	−.04	.01	.48^*	.84^*	1^*
14 CAQ-G_Pos	.54^*	.46^*	.56^*	−.56^*	−.30^*	−.28^*	−.43^*	−.40^*	−.11	.02	.53^*	.86^*	.55^*	1^*
15 CAQ-G	.53^*	.51^*	.58^*	−.67^*	−.30^*	−.28^*	−.46^*	−.50^*	−.09	.02	.57^*	.96^*	.87^*	.89^*	1^*

Note: ^* indicates significance below p ≤ .05 (adjusted for multiple testing); MPI Multidimensional Pain Inventory, BPI Brief Pain Inventory, PHQ 9 Patient Health Questionnaire (9 items version), GAD 7 Generalized Anxiety Disorder questionnaire (7 item version), NRS Numeric Rating Scale of Pain Intensity, SF12_PCS Health related quality of life the Short Form 12 (physical), SF12_MCS Health related quality of life the Short Form 12 (mental health), FHA II German version of the Acceptance and Action Questionnaire – II (AAQ-II), low values indicate high flexibility, CPAQ AE Chronic Pain Acceptance Questionnaire activity engagement scale, CPAQ PW Chronic Pain Acceptance Questionnaire pain willingness scale, CPAQ Total Chronic Pain Acceptance Questionnaire, CAQ-G German version of the committed action questionnaire, CAQ-G_neg includes only negative keyed items, CAQ-G_pos includes only positive keyed items, CAQ-8-G German version of the English short version of the CAQ